APO RESEARCH · REPORT
Procalcitonin Antibody
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Product & engineering
Understand the product.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Selected research
Industry Research
Procalcitonin Antibody Industry Research Report 2026
Market perspective
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
In China, Procalcitonin Antibody key players include Thermo Fisher, Wondfo , Ningbo Medicalsystem Biotechnology, bioMerieux, Snibe, etc. The top five players hold a share about 35%.
East China is the largest market, with a share about 25%, followed by South China and Southeast China, having a total share about 30 percent.
Read the full market overview
In terms of product, Monoclonal Procalcitonin Antibody is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital, followed by Medical research institutions, etc.
Report Scope
This report quantifies the global Procalcitonin Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/mg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Procalcitonin Antibody Market by Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Procalcitonin Antibody Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Procalcitonin Antibody Segment by Application
Hospital
Medical research institutions
Others
Procalcitonin Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Procalcitonin Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Procalcitonin Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Procalcitonin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal Procalcitonin Antibody
- Monoclonal Procalcitonin Antibody
Applications
- Hospital
- Medical research institutions
- Others
Companies covered
- Thermo Fisher
- Roche Diagnostics
- bioMerieux
- HyTest
- Wondfo
- Ningbo Medicalsystem Biotechnology
- Snibe
- Vazyme Biotech
- Getein Biotech
- Hotgen Biotech
- Lumigenex
- Shanghai Medicine'nest Pharmaceutical
- Kitgen
- Beijing KeyGen
- Fantibody
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Procalcitonin Antibody Market Size (2021-2032)
- 2.2.2 Global Procalcitonin Antibody Sales (2021-2032)
- 2.2.3 Global Procalcitonin Antibody Market Average Price (2021-2032)
- 2.3 Procalcitonin Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyclonal Procalcitonin Antibody
- 2.3.3 Monoclonal Procalcitonin Antibody
- 2.4 Procalcitonin Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Medical research institutions
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Procalcitonin Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Procalcitonin Antibody Sales (mg) of Manufacturers (2021-2026)
- 3.3 Global Procalcitonin Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global Procalcitonin Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global Procalcitonin Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Procalcitonin Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Procalcitonin Antibody, Product Type & Application
- 3.8 Global Manufacturers of Procalcitonin Antibody, Established Date
- 3.9 Global Procalcitonin Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher
- 4.1.1 Thermo Fisher Company Information
- 4.1.2 Thermo Fisher Business Overview
- 4.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Procalcitonin Antibody Product Portfolio
- 4.1.5 Thermo Fisher Recent Developments
- 4.2 Roche Diagnostics
- 4.2.1 Roche Diagnostics Company Information
- 4.2.2 Roche Diagnostics Business Overview
- 4.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Diagnostics Procalcitonin Antibody Product Portfolio
- 4.2.5 Roche Diagnostics Recent Developments
- 4.3 bioMerieux
- 4.3.1 bioMerieux Company Information
- 4.3.2 bioMerieux Business Overview
- 4.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 bioMerieux Procalcitonin Antibody Product Portfolio
- 4.3.5 bioMerieux Recent Developments
- 4.4 HyTest
- 4.4.1 HyTest Company Information
- 4.4.2 HyTest Business Overview
- 4.4.3 HyTest Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HyTest Procalcitonin Antibody Product Portfolio
- 4.4.5 HyTest Recent Developments
- 4.5 Wondfo
- 4.5.1 Wondfo Company Information
- 4.5.2 Wondfo Business Overview
- 4.5.3 Wondfo Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wondfo Procalcitonin Antibody Product Portfolio
- 4.5.5 Wondfo Recent Developments
- 4.6 Ningbo Medicalsystem Biotechnology
- 4.6.1 Ningbo Medicalsystem Biotechnology Company Information
- 4.6.2 Ningbo Medicalsystem Biotechnology Business Overview
- 4.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product Portfolio
- 4.6.5 Ningbo Medicalsystem Biotechnology Recent Developments
- 4.7 Snibe
- 4.7.1 Snibe Company Information
- 4.7.2 Snibe Business Overview
- 4.7.3 Snibe Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Snibe Procalcitonin Antibody Product Portfolio
- 4.7.5 Snibe Recent Developments
- 4.8 Vazyme Biotech
- 4.8.1 Vazyme Biotech Company Information
- 4.8.2 Vazyme Biotech Business Overview
- 4.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Vazyme Biotech Procalcitonin Antibody Product Portfolio
- 4.8.5 Vazyme Biotech Recent Developments
- 4.9 Getein Biotech
- 4.9.1 Getein Biotech Company Information
- 4.9.2 Getein Biotech Business Overview
- 4.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Getein Biotech Procalcitonin Antibody Product Portfolio
- 4.9.5 Getein Biotech Recent Developments
- 4.10 Hotgen Biotech
- 4.10.1 Hotgen Biotech Company Information
- 4.10.2 Hotgen Biotech Business Overview
- 4.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hotgen Biotech Procalcitonin Antibody Product Portfolio
- 4.10.5 Hotgen Biotech Recent Developments
- 4.11 Lumigenex
- 4.11.1 Lumigenex Company Information
- 4.11.2 Lumigenex Business Overview
- 4.11.3 Lumigenex Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lumigenex Procalcitonin Antibody Product Portfolio
- 4.11.5 Lumigenex Recent Developments
- 4.12 Shanghai Medicine'nest Pharmaceutical
- 4.12.1 Shanghai Medicine'nest Pharmaceutical Company Information
- 4.12.2 Shanghai Medicine'nest Pharmaceutical Business Overview
- 4.12.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product Portfolio
- 4.12.5 Shanghai Medicine'nest Pharmaceutical Recent Developments
- 4.13 Kitgen
- 4.13.1 Kitgen Company Information
- 4.13.2 Kitgen Business Overview
- 4.13.3 Kitgen Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Kitgen Procalcitonin Antibody Product Portfolio
- 4.13.5 Kitgen Recent Developments
- 4.14 Beijing KeyGen
- 4.14.1 Beijing KeyGen Company Information
- 4.14.2 Beijing KeyGen Business Overview
- 4.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Beijing KeyGen Procalcitonin Antibody Product Portfolio
- 4.14.5 Beijing KeyGen Recent Developments
- 4.15 Fantibody
- 4.15.1 Fantibody Company Information
- 4.15.2 Fantibody Business Overview
- 4.15.3 Fantibody Procalcitonin Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Fantibody Procalcitonin Antibody Product Portfolio
- 4.15.5 Fantibody Recent Developments
5 Global Procalcitonin Antibody Market Scenario by Region
- 5.1 Global Procalcitonin Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Procalcitonin Antibody Sales by Region: 2021-2032
- 5.2.1 Global Procalcitonin Antibody Sales by Region: 2021-2026
- 5.2.2 Global Procalcitonin Antibody Sales by Region: 2027-2032
- 5.3 Global Procalcitonin Antibody Revenue by Region: 2021-2032
- 5.3.1 Global Procalcitonin Antibody Revenue by Region: 2021-2026
- 5.3.2 Global Procalcitonin Antibody Revenue by Region: 2027-2032
- 5.4 North America Procalcitonin Antibody Market Facts & Figures by Country
- 5.4.1 North America Procalcitonin Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Procalcitonin Antibody Sales by Country (2021-2032)
- 5.4.3 North America Procalcitonin Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Procalcitonin Antibody Market Facts & Figures by Country
- 5.5.1 Europe Procalcitonin Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Procalcitonin Antibody Sales by Country (2021-2032)
- 5.5.3 Europe Procalcitonin Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Procalcitonin Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific Procalcitonin Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Procalcitonin Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Procalcitonin Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Procalcitonin Antibody Market Facts & Figures by Country
- 5.7.1 South America Procalcitonin Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Procalcitonin Antibody Sales by Country (2021-2032)
- 5.7.3 South America Procalcitonin Antibody Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Procalcitonin Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Procalcitonin Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Procalcitonin Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Procalcitonin Antibody Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Procalcitonin Antibody Sales by Type (2021-2032)
- 6.1.1 Global Procalcitonin Antibody Sales by Type (2021-2032) & (mg)
- 6.1.2 Global Procalcitonin Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global Procalcitonin Antibody Revenue by Type (2021-2032)
- 6.2.1 Global Procalcitonin Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Procalcitonin Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global Procalcitonin Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Procalcitonin Antibody Sales by Application (2021-2032)
- 7.1.1 Global Procalcitonin Antibody Sales by Application (2021-2032) & (mg)
- 7.1.2 Global Procalcitonin Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global Procalcitonin Antibody Revenue by Application (2021-2032)
- 7.2.1 Global Procalcitonin Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Procalcitonin Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global Procalcitonin Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Procalcitonin Antibody Value Chain Analysis
- 8.1.1 Procalcitonin Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Procalcitonin Antibody Production Mode & Process
- 8.2 Procalcitonin Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Procalcitonin Antibody Distributors
- 8.2.3 Procalcitonin Antibody Customers
9 Global Procalcitonin Antibody Analyzing Market Dynamics
- 9.1 Procalcitonin Antibody Industry Trends
- 9.2 Procalcitonin Antibody Industry Drivers
- 9.3 Procalcitonin Antibody Industry Opportunities and Challenges
- 9.4 Procalcitonin Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst